April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The Bioengineered Lacrimal Gland Using Cells Derived from Different Transgenic Mice: as a Novel Experimental Model for a Lacrimal Gland Biological Analysis
Author Affiliations & Notes
  • Masatoshi Hirayama
    Ophthalmology, Keio Univ School of Medicine, Tokyo, Japan
  • Tetsuya Kawakita
    Ophthalmology, Keio Univ School of Medicine, Tokyo, Japan
  • Shigeto Shimmura
    Ophthalmology, Keio Univ School of Medicine, Tokyo, Japan
  • Kazuo Tsubota
    Ophthalmology, Keio Univ School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships Masatoshi Hirayama, None; Tetsuya Kawakita, None; Shigeto Shimmura, None; Kazuo Tsubota, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1300. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Masatoshi Hirayama, Tetsuya Kawakita, Shigeto Shimmura, Kazuo Tsubota; The Bioengineered Lacrimal Gland Using Cells Derived from Different Transgenic Mice: as a Novel Experimental Model for a Lacrimal Gland Biological Analysis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1300. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The lacrimal gland, which develops through an epithelial-mesenchymal interaction during organ development, consists of acini, duct, myoepithelial cells and its peripheral tissues. Various types of cells are involved in the lacrimal gland development and regeneration process including tissue repair, however, it is difficult to analyze the origin and the kinetic of these cells. Here, we report a bioengineered lacrimal gland, which used cells derived from different transgenic mice as a model for analysis of the biology of the lacrimal gland development.

Methods: The care and handling of animals were performed in accordance with NIH guidelines. Protocols were approved by the Animal Care and Use Committee. We had successfully demonstrated the bioengineered lacrimal gland germ regeneration by organ germ method (ARVO2013). We regenerated the bioengineered lacrimal gland germ by using epithelial cells from transgenic mice and mesenchymal cells from the normal mice, and transplanted them to adult lacrimal gland defect model mouse. The development of the GFP-labelled bioengineered lacrimal gland, three-dimensional epithelial tissue morphology and the duct connection between the recipient and the bioengineered lacrimal gland were analyzed.

Results: The bioengineered lacrimal gland using cells from GFP transgenic mice was successfully developed at the transplantation site with duct connection between the bioengineered lacrimal excretory duct and the recipient’s lacrimal excretory duct. The epithelial cells of excretory lacrimal duct of the bioengineered gland, which were derived from DsRed-labelled epithelial cells, were successfully connected with the recipient’s lacrimal excretory duct epithelium histologically. The three dimensional morphological analysis revealed the GFP-labelled epithelial cells developed into branching morphogenesis, and it also revealed that myoepithelial cells were derived from epithelial cells during organ development.

Conclusions: We demonstrated that bioengineered lacrimal gland regeneration using cells derived from transgenic mice as a useful model to analyze the morphology and the developmental biology of the lacrimal gland. This model is expected to be applied for the analysis to clarify the biology of the lacrimal gland regeneration.

Keywords: 497 development • 687 regeneration • 576 lacrimal gland  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×